Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Updates in the Management of Severe Sepsis and Septic Shock

By Matthew Carvey, MD; and Jonathan Glauser, MD, MBA, FACEP | on June 12, 2024 | 1 Comment
Features
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

In summary, qSOFA should not be used as a single screening tool for sepsis. NEWS, MEWS, or SIRS may be more beneficial at this time.

You Might Also Like
  • Vitamin C Not a Magical Cure for Severe Sepsis and Septic Shock
  • Sepsis and Septic Shock Get New International Consensus Definitions
  • Opinion: How the Surviving Sepsis Campaign Got Almost Everything Wrong
Explore This Issue
ACEP Now: Vol 43 – No 06 – June 2024

2. Lactate clearance and capillary refill time (CRT)

Most institutions are beginning to transition to electronic health record-generated order sets for sepsis when it is suspected by the practitioner; however, the “necessary” labs to obtain have varied by clinical center. Specifically, lactate clearance has been a debatable topic since its inception. The SSC guidelines for 2021 weakly recommended measuring blood lactate and, if elevated (defined as ≥4 mmol/L), guiding resuscitation by a decrease in its value over time.7 The ANDROMEDA-SHOCK study evaluated whether targeting resuscitation towards a CRT versus lactate clearance led to a reduced mortality at 28 days; ultimately, there was no detectable difference. The CRT group’s mortality rate was 34.9 percent versus 43.4 percent in the lactate group.9 A concern raised with both strategies was whether volume overload and its early recognition was key to preventing further complications as a result of over-resuscitation. ACEP’s own clinical policy does not recommend the use of serum lactate levels to guide ongoing IV fluid resuscitation, as it has not been found to be an accurate marker of ongoing fluid needs.10

In summary, there is no good “endpoint” guiding resuscitation in septic shock, but CRT or lactate clearance can be considered.

3. Intravenous fluids

One of the greatest controversies in the care of sepsis has been intravenous fluid management during the acute stages of septic shock. For patients in septic shock or exhibiting signs of hypoperfusion, SSC guidelines weakly recommend at least 30 mL/kg of intravenous crystalloid within the first three hours of resuscitation.7 The current fluid recommendation is a balanced crystalloid, with lactated ringers being superior to normal saline.5 The CLOVERS trial investigated conventional fluid resuscitation versus early vasopressor use and intravenous fluid restriction, with the conventional group receiving approximately 3.8 L and the fluid restriction group receiving 1.8 L. Researchers concluded that at 90 days, mortality and adverse events of the aforementioned volumes were similar between the two groups.11 Notably, ACEP’s clinical policy does not endorse an empirical fluid bolus but, rather, individualized fluid resuscitation needs for each patient.10 The judicious amount of intravenous fluids cited by the SSC should also be liberalized for patients with clinical findings of volume overload or a known reduced ejection fraction.

In summary, the current recommendation is 30 mL/kg of lactated ringers within the first three hours of resuscitation, with the caveat of utilizing clinical judgment to prevent fluid overload.

Pages: 1 2 3 4 5 6 | Single Page

Topics: ClinicalCritical CareGuidelinesInfectious DiseaseSepsis

Related

  • Why the Nonrebreather Should be Abandoned

    December 3, 2025 - 0 Comment
  • Non-Invasive Positive Pressure Ventilation in the Emergency Department

    October 1, 2025 - 0 Comment
  • Emergency Department Management of Prehospital Tourniquets

    October 1, 2025 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

One Response to “Updates in the Management of Severe Sepsis and Septic Shock”

  1. July 1, 2024

    Joseph R Shiber, MD Reply

    Dear ACEPNow Editor,

    Excellent synopsis of ED treatment of septic shock but I would like to add a few clarifications. The preferred balanced IVF is Plasmalyte-A since LR is somewhat hypotonic (Na 130) and uses lactate as a buffer, compared to acetate and gluconate in Plasmalyte-A (Na 140). The additional lactate is not actually detrimental to cellular activity but can hamper the usefulness of tracking lactate levels especially with hepatic or mitochondrial dysfunction where lactate is not being converted back to pyruvate for preparation to enter the TCA cycle. The optimal vasopressor for septic shock should correct the hemodynamic disorder(s) causing the tissue hypoxia. Levophed is certainly the most useful to help restore vascular tone (alpha effect) in the low SVR vasodilatory state of distributive shock while supplying a small B1-2 effect but there are cases where an inappropriate heart-rate response occurs (HR <80) due to medications (such as AVN blockers) or to intrinsic chronotropic failure (age or sepsis related). In these cases, it is paramount to address the heart rate at the same time, since if the heart rate remains inappropriately low while simply increasing SVR the cardiac output and tissue perfusion will potentially go down not up. Lastly, although ECMO is well recognized as a rescue for ARDS (V-V) and circulatory shock (V-A) it should be noted that active bacteremia or fungemia is a contraindication since the circuit will be contaminated immediately and cannot be sterilized.

    Respectfully,
    Joseph Shiber, MD, FACEP, FACP, FNCS, FCCM

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603